Abbott Laboratories (XSWX:ABT) Price-to-Tangible-Book: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
82 GF Score
Price CHF84.50
GF Value CHF109.21
! 1 Warning Sign
View Full Analysis

What is Abbott Laboratories Price-to-Tangible-Book?

As of today (2026-09-21), Abbott Laboratories's share price is CHF84.50. Abbott Laboratories's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was CHF-0.32. Hence, Abbott Laboratories's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Abbott Laboratories's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Abbott Laboratories's highest Price to Tangible Book Ratio was 88.33. The lowest was 6.80. And the median was 22.50.

XSWX:ABT's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.7
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Abbott Laboratories's share price is CHF84.50. Abbott Laboratories's Book Value per Sharefor the quarter that ended in Jun. 2026 was CHF24.13. Hence, Abbott Laboratories's P/B Ratio of today is 3.50.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Abbott Laboratories Price-to-Tangible-Book Related Terms


Abbott Laboratories Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Price-to-Tangible-Book Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,214.29 51.96 30.25 9.85 9.35

Abbott Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.06 10.28 9.35 - -

XSWX:ABT vs SYK, MDT, BSX: Price-to-Tangible-Book Comparison

For the Medical Devices subindustry, Abbott Laboratories's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories Price-to-Tangible-Book vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Price-to-Tangible-Book falls into.


XSWX:ABT
82GF Score
Abbott Laboratories XSWX:ABT
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Price-to-Tangible-Book Calculation

Abbott Laboratories's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=84.50/-0.323
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF84.50 is trading 22.6% below its estimated GF Value™ of CHF109.21.

Key valuation signals for XSWX:ABT:

  • Price-to-Tangible-Book:
  • GF Value™: CHF109.21 vs. price of CHF84.50 (22.6% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
82GF Score

Get the complete analysis for XSWX:ABT

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF84.50
Price
CHF109.21
GF Value